ibusinesslines.com
ibusinesslines.com October 23, 2017


FDA approves electroCore's treatment for cluster headaches

20 April 2017, 03:27 | Melissa Porter

FDA approves electroCore's treatment for cluster headaches

FDA approves electroCore's treatment for cluster headaches

The GammaCore device interferes with pain signals transmitted through the vagus nerve, which connects the brain and the gut. The FDA's release is based on analyses of data from 2 clinical trials, ACT1 and ACT2, which evaluated the safety and efficacy of gammaCore for the acute treatment of episodic cluster headache. Both trials were prospective, double-blind, placebo-controlled, randomized studies which evaluated the use of gammaCore vs. placebo. It promises to relieve the pain of cluster headaches by providing electric stimulation when held against the neck.


Any use of rescue medication within 60 minutes was considered a treatment failure. In ACT2, which included 27 patients with episodic cluster headache, more patients using the VNS system experienced pain reduction compared with placebo (47.5% versus 6.2%, P=0.003). The product is a handheld, noninvasive, easy-to-use device that provides a new option for adults with the headache disorder. And it seems like blocking that path can lead to effective relief: A study published in Headache a year ago found that 27 percent of people with cluster headaches felt better 15 minutes after using it, compared to 15 percent patients who got a placebo. "It does not have the side effects or dose limitations of commonly prescribed treatments or the need for invasive implantation procedures, which can be inconvenient, costly and high-risk", Dr. Stephen Silberstein of Philadelphia's Jefferson University said in a prepared statement. They predominantly affect males and usually manifest by the age of 30.



Other News

Trending Now

Mortgage income provides boost to Fulton Financial's quarterly results
The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink . The company reported $0.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.67 by $0.01.

Korea not to fight
Next week, US Secretary of State Rex Tillerson will chair a minister-level meeting on the North Korean issue at the UN. China has been slow to support statements condemning North Korea in the past, but signed off on the message Wednesday.

Pence, Mattis fire verbal volleys at North Korea
Foreign Ministry spokesman Lu Kang said tensions need to be eased on the Korean Peninsula to bring the escalating dispute to a peaceful resolution.

Nation by nation, how Trump has shaken up Koreas, neighbors
Klem also noted the sudden " surge in trademark filings by unrelated third parties trying to capitalize on the name ". There are trademarks applications in 10 countries still awaiting approval, according to the New York Times .

Samsung joins Amazon for HDR tech
Samsung has also partnered with YouTube and other companies that can deliver HDR content and integrate it into its products. The South Korean tech giant will provide various streaming services based on HDR10 Plus on the Amazon Prime Video app.

Chevy Chase Trust Holdings Inc. Boosts Position in Leucadia National Corp. (LUK)
Pastel & Associes SA acquired a new stake in shares of Leucadia National Corporation during the second quarter worth $12,094,000. COPYRIGHT VIOLATION WARNING: This piece was reported by Community Financial News and is owned by of Community Financial News.

No reason to believe gays abused in Chechnya
As a dynamic media force, GLAAD tackles tough issues to shape the narrative and provoke dialogue that leads to cultural change. Global condemnations against Chechnya have increased in the past week amidst reports of anti-gay kidnappings and torture.